Our current findings raise the intriguing possibility that YME1L inhibition may limit tumour growth both by preventing metabolic reprogramming of mitochondria and by promoting mtDNA-dependent inflammation and the production of type I interferons, which are known to induce senescence in numerous human cancers48. The gene discussed is YME1L1; the disease is neoplasm.